Molecular pharming, or using live plants or plant cells to produce biopharmaceuticals, is not a new concept, but it is gaining adherents, say Matthew McNulty and Karen McDonald of the Department of Chemical Engineering at the University of California at Davis. Molecular pharming is generally less expensive than conventional biomanufacturing, but the upstream portion of the process involves some plant cultivation in a controlled environment that requires specific equipment and systems.